Stock Events

Stock Events

Pediapharm 

C$130.56
3
+C$0.00+0%Tuesday 20:00

Statistics

Day High
130.56
Day Low
130.56
52W High
130.56
52W Low
130.56
Volume
138
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Nov 27Expected
Q4 2016
Q4 2016
Q2 2017
Q4 2017
Q3 2018
-0.04
-0.03
-0.02
-0.01
Expected EPS
-0.01
Actual EPS
-0.04

Financials

1.2%Profit Margin
Profitable
2017
2018
2019
2020
2021
2022
144.69MRevenue
1.74MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson offers a broad range of pediatric pharmaceuticals, directly competing in Pediapharm's market.
Pfizer
PFE
Mkt Cap158.45B
Pfizer develops and markets drugs for various pediatric conditions, overlapping with Pediapharm's product offerings.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie, with its pediatric divisions, competes in similar therapeutic areas as Pediapharm.
GSK
GSK
Mkt Cap94.23B
GlaxoSmithKline produces medications for children, including vaccines and antibiotics, competing with Pediapharm.
Merck
MRK
Mkt Cap356.01B
Merck manufactures pediatric medicines and vaccines, which are in direct competition with Pediapharm's products.
Novartis
NVS
Mkt Cap268B
Novartis offers pediatric pharmaceuticals, including treatments for chronic diseases in children, competing with Pediapharm.
Sanofi
SNY
Mkt Cap95.65B
Sanofi provides a range of pediatric healthcare solutions, including vaccines and chronic disease treatments.
Bristol-Myers Squibb
BMY
Mkt Cap124.91B
Bristol Myers Squibb develops drugs that address serious diseases in children, competing in the same space as Pediapharm.
Astrazeneca
AZN
Mkt Cap243.34B
AstraZeneca has a significant pediatric segment that produces drugs for various child-specific ailments.
Roche
RHHBY
Mkt Cap334.28B
Roche, through its Genentech division, develops medications for pediatric patients, including oncology and immunology.

About

Pediapharm Inc. operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children. The company was incorporated in 2003 and is headquartered in Verdun, Canada.
Show More
CEO
Country
Canada
ISIN
CA70533E1088

Listings

V
CA
PDP.V

0 Comments

Share your thoughts

FAQs

What is Pediapharm stock price today?▼
The current price of PDP.V is C$130.56 CAD — it has increased by +0% in the past 24 hours. Watch Pediapharm stock price performance more closely on the chart.
What is Pediapharm stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on TSX Venture Exchange exchange Pediapharm stocks are traded under the ticker PDP.V.
What were Pediapharm earnings last quarter?▼
PDP.V earnings for the last quarter are -0.04 CAD per share, whereas the estimation was -0.01 CAD resulting in a -300% surprise. The estimated earnings for the next quarter are N/A CAD per share.
What is Pediapharm revenue for the last year?▼
Pediapharm revenue for the last year amounts to 144.69M CAD.
What is Pediapharm net income for the last year?▼
PDP.V net income for the last year is 1.74M CAD.
In which sector is Pediapharm located?▼
Pediapharm operates in the Materials sector.
When did Pediapharm complete a stock split?▼
The last stock split for Pediapharm was on December 20, 2018 with a ratio of 1:15.